French medical technology company Balt has acquired US-based medical device company Blockade Medical for an undisclosed amount.

Established in 2011, Blockade Medical has experience of more than 65 years in the neurovascular field and specialises in the development of catheter based therapeutic devices for the treatment of cerebral aneurysms.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The transaction is aligned with Balt’s strategy of emerging as a global leader in the neurovascular field, as well as increasing its footprint in the US.

"The transaction has enhanced BALT’s product portfolio with the addition of Blockade’s Barricade Coil System."

BALT International president and BALT CEO Pascal Girin said: “This acquisition is a first strategic move towards transforming BALT into an integrated global neurovascular device company.

“BALT is recognised as a first mover in the market thanks to a world-class R&D team, which has proven its ability and rapidity to develop blockbuster products such as the LEO stent, the SILK flow diverter and the SONIC detachable tip micro catheter.

See Also:

“Blockade will nicely complement our product portfolio and will give us a strong expandable US based platform for our future development.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The transaction has enhanced BALT’s product portfolio with the addition of Blockade’s Barricade Coil System.

The Barricade Coil System is a range of platinum coils varying in sizes to frame, fill and finish aneurysms with reduced shelf space requirements.

The coils feature a short, flexible detachment zone to facilitate faster detachment times and minimal microcatheter recoil.

The company will also develop and commercialise additional neurovascular devices for the treatment of aneurysms, stroke and other neurovascular conditions.